Biography
Aliya Omer leads the global strategy and execution of the hematology and cell therapy portfolio, across hematology and solid tumors at AstraZeneca. Previously, Aliya served as Vice President, US Franchise Head, Breast Cancer at AstraZeneca. Aliya has over 20 years of experience in the pharmaceutical, biotechnology and consumer healthcare industries, with a strong record of success leading across functions and all stages of the product lifecycle. Before joining AstraZeneca, Aliya served as Vice President, Corporate Development Head of Global Portfolio and Program Strategy at Kite Pharma, a Gilead company, where she played a key leadership role in shaping the future direction of Kite and establishing it as a global leader in cell therapy. Previously, Aliya spent twelve years at Novartis Oncology where she led multiple commercial teams in the US and Latin America. Aliya started her career in research and development at Johnson and Johnson.